Cochrane · systematic review · CD003115

Oral or transdermal opioids for osteoarthritis of the knee or hip

da Costa, BR, Nüesch, E, Kasteler, R, et al. · Cochrane Database of Systematic Reviews · 2014 · Cochrane Library

Musculoskeletal2 versionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
6
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 1 · 16.7%Moderate 2 · 33.3%High 3 · 50%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Current version only

Oral or transdermal opioids compared with placebo for osteoarthritis of the knee or hip

Population: participants with osteoarthritis of the knee or hip
CD003115.PUB4 (current) · 6 questions
OutcomeEffectEvidenceStatus / GRADE
Pain intensity Various pain scales. (median
Oral or transdermal opioids vs placebo
no estimate extracted22 studies · 8275 participantsHigh
Function Various validated function scales. (median
Oral or transdermal opioids vs placebo
no estimate extracted12 studies · 3553 participantsHigh
Number of participants experiencing any adverse event (median
Oral or transdermal opioids vs placebo
RR 1.49 [1.35, 1.63]9 studies · 4898 participantsModerate
Downgraded: risk of bias
Number of participants who withdrew because of adverse events (median
Oral or transdermal opioids vs placebo
RR 3.76 [2.93, 4.82]19 studies · 7712 participantsHigh
Number of participants experiencing any serious adverse event (median
Oral or transdermal opioids vs placebo
RR 3.35 [0.83, 13.56]3 studies · 681 participantsLow
Downgraded: risk of bias
Withdrawal symptoms (median
Oral or transdermal opioids vs placebo
OR 2.67 [2.02, 3.77]3 studies · 1151 participantsModerate
Downgraded: risk of bias

Comparison

Population: Patients with osteoarthritis of the knee or hip
CD003115.PUB3 · 6 questions
OutcomeEffectEvidenceStatus / GRADE
Pain intensity Various pain scales. (median
no estimate extracted10 studies · 2268 participantsHigh
Function Various validated function scales. (median
no estimate extracted7 studies · 1794 participantsHigh
Number of patients experiencing any adverse event (median
RR 1.55 [1.41, 1.7]4 studies · 1080 participantsModerate
Downgraded: risk of bias
Number of patients who withdrew because of adverse events (median
RR 4.05 [3.06, 5.38]10 studies · 2403 participantsHigh
Number of patients experiencing any serious adverse event (median
RR 3.35 [0.83, 13.56]3 studies · 681 participantsLow
Downgraded: risk of bias
Withdrawal symptoms Short Opiate Withdrawal Scale. (
SMD 0.6 [0.42, 0.79]1 study · 499 participantsLow
Downgraded: risk of bias